Physician profile
Darryl Turner
NPI 1982986279
$20,967.70
in general payments reported to CMS, 2019-2025
24 companies · $1,261 in 2025
The $1,261 reported for 2025 was more than what 90% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $115 · 2023: $290 · 2024: $19K · 2025: $1,261.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $11K · Travel and Lodging: $5,987 · Food and Beverage: $2,719 · Consulting Fee: $729.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $11,418.00 |
| Travel and Lodging | $5,987.18 |
| Food and Beverage | $2,718.92 |
| Consulting Fee | $728.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $17,804.66 | 2024-2025 | Rivfloza |
| Boston Scientific Corporation | $1,500.34 | 2024 | Ams 700 Cxr Rte Kit, Ams 800 Artificial Urinary Sphincter, Ams 700 |
| Sumitomo Pharma America, INC. | $251.50 | 2023-2025 | Gemtesa, Orgovyx |
| Axonics, INC. | $193.55 | 2022-2024 | Axonics, Bulkamid |
| Urogen Pharma, INC. | $163.36 | 2024-2025 | |
| Abbvie INC. | $145.88 | 2024-2025 | |
| Laborie Medical Technologies Corp. | $108.92 | 2023-2024 | Urgent PC Neuromodulation System |
| Srs Medical Systems, INC. | $107.16 | 2025 | Ct3000 Pro Base Unit, Urocuff-Dc Disposable, Single |
| Progenics Pharmaceuticals, INC. | $89.69 | 2023-2025 | Pylarify |
| Dendreon Pharmaceuticals LLC | $85.43 | 2024-2025 | Provenge |
| Pfizer INC. | $81.21 | 2024-2025 | |
| Endo USA, INC. | $62.79 | 2024 | Xiaflex |
| Antares Pharma, INC. | $57.90 | 2023-2025 | Xyosted, Nocdurna, Tlando |
| Endo Pharmaceuticals INC. | $55.21 | 2022-2023 | Xiaflex |
| Astellas Pharma US INC | $54.70 | 2022-2024 | Xtandi |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $34.97 | 2022 | |
| 180 Medical, INC. | $29.84 | 2023 | Gentlecath Glide |
| Teleflex LLC | $28.30 | 2025 | Urolift |
| Ferring Pharmaceuticals INC. | $23.79 | 2024 | Adstiladrin |
| Myovant Sciences INC. | $20.61 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $19.88 | 2023 | Seglentis |
| Coloplast Corp | $16.85 | 2025 | |
| Photocure INC | $15.76 | 2025 | Cysview |
| Halozyme INC | $15.40 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Darryl Turner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.